Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2003
11/20/2003US20030216308 NOVX polynucleotides and polypeptides utilized in the detection and treatment of a broad range of pathological states
11/20/2003US20030216305 Identification and characterization of a polypeptide having homology to the sarcoma-amplified protein SAS
11/20/2003US20030216277 Stabilization of enzymes
11/20/2003US20030215949 Dehydroascorbate reductase ("DHAR") genes and their uses
11/20/2003US20030215930 Genes involved in cyclododecanone degradation pathway
11/20/2003US20030215929 Useful for conversion of aldoxime substrates to nitrilases and other downstream intermediates; gene has been cloned into recombinant host and expressed
11/20/2003US20030215928 Preparing geneticaly engineered transferase which will modify maltodextrins and cyclotextrins for sweeteners; textile treatments; detergents; ethanol production
11/20/2003US20030215927 UDP-glucosyltransferases
11/20/2003US20030215925 Topoisomerase-based reagents and methods for molecular cloning
11/20/2003US20030215920 Comprises nucleotide sequences coding pichia oxidoreductase for use as selectable marker in genetic engineering
11/20/2003US20030215919 Phosphodiesterase 8A
11/20/2003US20030215915 Cytochrome P450 expression in enterobacteria
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215907 Comprise nucleotide sequences coding enzymatic polypeptide for use as modification and selection tools in genetic engineering
11/20/2003US20030215906 Recombinant bacillus proteases and uses thereof
11/20/2003US20030215904 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
11/20/2003US20030215898 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
11/20/2003US20030215893 Nucleic acids, proteins, and antibodies
11/20/2003US20030215883 Preparing and screening gene libraries for bioactive proteins with altered heat resistance
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
11/20/2003US20030215870 Isolated and purified 12R-lipoxygenase polypeptide and polynucleic acid encoding the same
11/20/2003US20030215859 Biocatalytic polypeptides having improved stereospecificity for production of hydroxycarboxylic acids and aryl/alkyl-hydroxy compounds; glycosyltransferases; improved solvent resistance of microorganisms used; drug screening
11/20/2003US20030215851 Protein phosphatases
11/20/2003US20030215850 Comprises nucleotide sequences coding thrombin-activatable fibrinolysis inhibitor (TAFI) for treatment, prevention and diagnosis of blood disorder
11/20/2003US20030215848 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
11/20/2003US20030215847 Comprises nucleotide sequences coding polypeptides for use in diagnosis, prevention and treatment of bone disorders; tissue engineering
11/20/2003US20030215836 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
11/20/2003US20030215833 Variant cleavage stimulation factor and its encoding nucleic acid
11/20/2003US20030215827 Comprises enzymatic polypeptide for use in diagnosis, treatment and prevention of cell proliferative and autoimmune/inflammatory disorders
11/20/2003US20030215820 Regulators of type-1tumor necrosis factor receptor and other cytokine receptor shedding
11/20/2003US20030215812 Gene encoding beta-mannanase, enzyme preparation and uses thereof
11/20/2003US20030215542 Reduction of cystine containing polypeptides such as gliadins, glutenins, albumin or globulins, using thioredoxin or transferase enzymes; deactivation of neurotoxins
11/20/2003US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes
11/20/2003US20030215449 Method of treating or delaying onset of angiogenic-associated disorder comprising administering to subject an antibody to the polypeptide of SEC1 in an amount sufficient to treat or prevent said angiogenic associated disorder
11/20/2003US20030215447 Produced by hybridoma cell line DSM ACC 2533
11/20/2003US20030215443 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/20/2003US20030215440 Antithrombotic thrombin variants
11/20/2003US20030215435 Expression system for effeiciently producing clinically effective lysosomal enzymes (glucocerebrosidase)
11/20/2003US20030215429 Lyophilised or sonicated Lactobacillus bacteria, grampositivie bacteria, gramnegative bacteria; antitumor agents, therapeutic treatment of autoimmune diseases, gastrointestinal disorders, nervodegenerative diseases
11/20/2003CA2485489A1 Nucleotide sequence coding for a mannitol 2-dehydrogenase and method for the production of d-mannitol
11/20/2003CA2485452A1 Process for generating sequence-specific proteases by directed evolution and use thereof
11/20/2003CA2485137A1 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content
11/20/2003CA2485125A1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use
11/20/2003CA2484211A1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2484001A1 Methods for increasing oil content in plants
11/20/2003CA2483497A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/20/2003CA2483025A1 Mammalian genes modulated during fasting and feeding
11/20/2003CA2474947A1 Combination of a growth factor and a protease enzyme
11/19/2003EP1362915A1 Nomuraeae rileyi -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same
11/19/2003EP1362914A2 Histone deacetylase inhibitor and use thereof
11/19/2003EP1362913A2 Interaction trap system for isolating proteins
11/19/2003EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof
11/19/2003EP1362597A1 Antigenic peptides derived from telomerase
11/19/2003EP1362120A1 Method for purification of soluble ssao
11/19/2003EP1362113A2 Constitutive promoter from arabidopsis
11/19/2003EP1362108A2 Novel human protease and polynucleotides encoding the same
11/19/2003EP1362107A2 Human phospholipase b-like polypeptide and uses thereof
11/19/2003EP1362099A2 Method of providing polypeptide preparations with reduced enzymatic side activities
11/19/2003EP1362097A2 Champ-a cardiac helicase-like factor
11/19/2003EP1362062A1 Concatameric immunoadhesion
11/19/2003EP1362058A2 Comparative ligand mapping from mhc positive cells
11/19/2003EP1362028A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
11/19/2003EP0988366B1 Detersive enzyme particles having water-soluble carboxylate barrier layer and compositions including same
11/19/2003EP0934425B1 Renilla luciferase and green fluorescent protein fusion genes
11/19/2003EP0888434B1 Enzymatic detergent composition and method for degrading and removing bacterial cellulose
11/19/2003EP0760859B1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines
11/19/2003EP0665890B1 Increased production of secreted proteins by recombinant eukaryotic cells
11/19/2003EP0640137B1 Immortalized human cell lines containing exogenous cytochrome p450 genes
11/19/2003CN1457364A Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular PHA depolymerase
11/19/2003CN1457362A DNA encoding novel D-aminoacylase and process for producing D-amino acid by using the same
11/19/2003CN1456672A Glyphosate tolerance-5-enolpyruvoyl shikimic acid-3-phosphoric acid synthesizing enzyme and its coding genes
11/19/2003CN1456671A Nucleotide series of shaogengen mould delta-6 fatty acid dehydrogenase and its use
11/19/2003CN1456668A Alkaline fungus serine proteinase and its preapring method and application
11/19/2003CN1456667A Method for producing thermally stable 2-amylase by thermophile
11/19/2003CN1456666A Production of pectase by solid mould oxalate fermenting
11/19/2003CN1456665A Production of organic phosphorous chemicals decomposing enzyme by silkworm bioreactor
11/19/2003CN1456664A Reorganized human glycogen phosphorylase isoenzyme BB and preparation thereof by methanal yeast and use thereof
11/19/2003CN1456662A Barm expressing system of plasminogen and purifying process
11/19/2003CN1128221C Gene encoding alkaline liquefying alpha-amylase
11/19/2003CN1128220C Process for separating worm kinase
11/19/2003CN1128219C Process for extracting Fe-contained SOD from spirulina
11/18/2003US6649814 Cytochrome P450 monooxygenases
11/18/2003US6649813 Induction of resistance to virus diseases by transformation of plants with a plant virus replicase gene
11/18/2003US6649811 Use of nimesulide for the preparation of a pharmaceutical formulation for treating a neurodegenerative condition
11/18/2003US6649782 Plants, seeds and oils having an elevated total monounsaturated fatty acid content
11/18/2003US6649748 Peroxidase genomic gene derived from ipomoea batatas and a promoter thereof
11/18/2003US6649744 Rnase P polypeptides, polynucleotides, and methods using their mechanisms of action
11/18/2003US6649741 Tumor antigen-derived gene (TADG) of given sequence; detecting binding of antibody to the protein; useful in diagnosis, treatment and prevention; breast and ovarian
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649597 Delivery vehicle construct which specifically binds to and stimulates endocytosis into cells expressing the activator
11/18/2003US6649595 FK506 binding proteins (FKBPs); rapamysin derivatives; multimerizing chimeric proteins in genetically engineered cells using said derivatives
11/18/2003US6649399 Given nucleotide sequence; use in therapeutic, diagnostic, and pharmacogenomic applications
11/18/2003US6649395 Screening for compounds which inhibit peptidyl-prolyl cis-trans isomerase activity; tryptophan at drug binding domain is substituted; use as parasiticide
11/18/2003US6649394 Topoisomerase IV, corresponding nucleotide sequences and uses thereof
11/18/2003US6649393 Mutant form of cytotoxic ribonucleolytic protein which allows production by recombinant methods
11/18/2003US6649392 Mutant form of a cytotoxic ribonucleolytic protein which allows production by recombinant methods
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
1 ... 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 ... 1416